apraclonidine has been researched along with Anti-MuSK Myasthenia Gravis in 1 studies
apraclonidine: relieves postoperative intraocular pressure following trabeculoplasty; RN given refers to parent cpd
apraclonidine : An imidazoline that is 2-amino 4,5-dihydro-1H-imidazoline in which one of the exocyclic amino hydrogens has been replaced by a 4-amino-2,6-dichlorophenyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agha, M | 1 |
| Ismail, H | 1 |
| Sawaya, R | 1 |
| Salameh, J | 1 |
1 trial available for apraclonidine and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Efficacy of apraclonidine eye drops in treating ptosis secondary to myasthenia gravis: A pilot clinical trial.
Topics: Blepharoptosis; Clonidine; Humans; Myasthenia Gravis; Ophthalmic Solutions; Retrospective Studies | 2023 |